Article
KIT genetic alterations in breast cancer.
Journal of clinical pathology - 14 Dec 2023
Vahdatinia Mahsa, Derakhshan Fatemeh, Da Cruz Paula Arnaud, Dopeso Higinio, Marra Antonio, Gazzo Andrea M, Brown David, Selenica Pier, Ross Dara S, Razavi Pedram, Zhang Hong, Weigelt Britta, Wen Hannah Y, Brogi Edi, Reis-Filho Jorge S, Pareja Fresia
Abstract excerpt
AIMS: Activating somatic mutations or gene amplification of KIT result in constitutive activation of its receptor tyrosine kinase, which is targetable in various solid tumours. Here, we sought to investigate the presence of KIT genetic alterations in breast cancer (BC) and characterise the histological and genomic features of these tumours. METHODS: A retrospective analysis of 5,575 BCs previously subjected to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
